CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Revance Therapeutics, Inc.  (RVNC)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Revance Therapeutics's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

RVNC Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change 0 % 0 % 0 % 0 % 0 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 579 # 831 # 613 # 669 # 665
Seq. Revenue Change 0 % 0 % 0 % 0 % 0 %
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Revance Therapeutics, Inc. experienced contraction in Gross Profit by 0 % to $0 millions and Revenue by 0 %, while Gross Margin fell to 100 % a new company low.

Observing first quarter 2017 results within Major Pharmaceutical Preparations industry 73 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 579, from total ranking in previous quarter at 831.
Learn about Gross Margin
RVNC's Gross Margin first quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 153
Overall # 579

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Revance Therapeutics's (Mar 31 2017) Gross Profit $ 0 RVNC's Income Statement
Revance Therapeutics's (Mar 31 2016) Gross Profit $ 0 Quarterly RVNC's Growth
RVNC's Profits by Division See RVNC's Profits by Segment

Other Gross Margin Profitability Ratios
RVNC's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
RVNC's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for RVNC's Competitors
Gross Margin Profit Margin for Revance Therapeutics's Suppliers
Gross Margin Profit Margin for RVNC's Customers

You may also want to know
RVNC's Annual Growth Rates RVNC's Profitability Ratios RVNC's Asset Turnover Ratio RVNC's Dividend Growth
RVNC's Roe RVNC's Valuation Ratios RVNC's Financial Strength Ratios RVNC's Gross Profit Growth
RVNC's Roa RVNC's Inventory Turnover Ratio RVNC's Growth Rates RVNC's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Major Pharmaceutical Preparations Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Seres Therapeutics, Inc.  100.00 %$ 3.015 $ 3.015 
Macrogenics Inc  100.00 %$ 2.055 $ 2.055 
Karyopharm Therapeutics Inc.  100.00 %$ 0.068 $ 0.068 
Jazz Pharmaceuticals Plc  100.00 %$ 376.053 $ 376.053 
Intra-cellular Therapies, Inc.  100.00 %$ 0.095 $ 0.095 
Nabriva Therapeutics Ag  100.00 %$ 1.678 $ 1.678 
Newlink Genetics Corp  100.00 %$ 2.761 $ 2.761 
Onconova Therapeutics, Inc.  100.00 %$ 0.210 $ 0.210 
Ophthotech Corp.  100.00 %$ 1.662 $ 1.662 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.213 $ 6.213 
Northwest Biotherapeutics Inc  100.00 %$ 0.068 $ 0.068 
Novan, Inc.  100.00 %$ 0.100 $ 0.100 
Abeona Therapeutics Inc.  100.00 %$ 0.186 $ 0.186 
Immunogen Inc  100.00 %$ 28.499 $ 28.499 
Endocyte Inc  100.00 %$ 0.013 $ 0.013 
Enanta Pharmaceuticals Inc  100.00 %$ 8.959 $ 8.959 
Eleven Biotherapeutics, Inc.  100.00 %$ 0.425 $ 0.425 
Dynavax Technologies Corp  100.00 %$ 0.148 $ 0.148 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.133 $ 0.133 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.185 $ 0.185 
Fibrogen Inc  100.00 %$ 26.891 $ 26.891 
Heat Biologics, Inc.  100.00 %$ 0.024 $ 0.024 
Ibio, Inc.  100.00 %$ 0.037 $ 0.037 
Genvec Inc  100.00 %$ 0.114 $ 0.114 
Geron Corp  100.00 %$ 0.537 $ 0.537 
Five Prime Therapeutics Inc  100.00 %$ 10.135 $ 10.135 
Progenics Pharmaceuticals Inc  100.00 %$ 2.347 $ 2.347 
Pharmathene, Inc  100.00 %$ 0.804 $ 0.804 
Syros Pharmaceuticals, Inc.  100.00 %$ 1.101 $ 1.101 
Innoviva, Inc.  100.00 %$ 40.492 $ 40.492 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com